Source:http://linkedlifedata.com/resource/pubmed/id/19570962
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2009-11-25
|
pubmed:abstractText |
Analysis of estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC) is increasingly being conducted in core needle biopsies (CNBs) taken at diagnosis but the concordance with the excisional biopsy (EB) is poorly documented.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1569-8041
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1948-52
|
pubmed:meshHeading |
pubmed-meshheading:19570962-Biopsy,
pubmed-meshheading:19570962-Biopsy, Needle,
pubmed-meshheading:19570962-Breast Neoplasms,
pubmed-meshheading:19570962-Early Diagnosis,
pubmed-meshheading:19570962-Female,
pubmed-meshheading:19570962-Humans,
pubmed-meshheading:19570962-Receptor, erbB-2,
pubmed-meshheading:19570962-Receptors, Estrogen,
pubmed-meshheading:19570962-Receptors, Progesterone,
pubmed-meshheading:19570962-Reproducibility of Results
|
pubmed:year |
2009
|
pubmed:articleTitle |
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).
|
pubmed:affiliation |
Department of Medicine, Breast Unit, The Royal Marsden Hospital and Institute of Cancer Research, London, UK. monica.arnedos@rmh.nhs.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|